‘Pharma Bro’ Martin Shkreli Tries to Monopolize Kanye West’s New Album With $10 Million Offer
Shkreli is facing fraud charges and has repeatedly affirmed his status as poster boy for Wall Street greed with his price-gouging practices while head of Turing Pharmaceuticals. So what's the "pharma bro" up to now? Apparently, trying to buy Kanye West's new album with the caveat that no one else can own it.He’s facing fraud charges and has repeatedly affirmed his status as poster boy for Wall Street greed with his price-gouging practices while head of Turing Pharmaceuticals. So what’s “pharma bro” Martin Shkreli up to now? Apparently, he’s trying to buy Kanye West’s new album, “The Life of Pablo,” with the caveat that no one else can own it.
Shkreli on Thursday made his $10 million offer to West public with a series of tweets, including one with an image of a letter addressed to the rapper (via @MartinShkreli):
aiyo @kanyewest last minute can i buy your album out so it dont get released publicly
— Martin Shkreli (@MartinShkreli) February 11, 2016
Here is my initial offer for the album. @kanyewest Thanks for your consideration and I look forward to your response pic.twitter.com/opJ7mlfraK
— Martin Shkreli (@MartinShkreli) February 11, 2016
Kanye and his label are legally required to take my offer letter to their Board of Directors. This should delay the album by a few days.
— Martin Shkreli (@MartinShkreli) February 11, 2016
There’s a certain logic to Shkreli’s gesture. The former hedge fund vigilante famously bought Wu-Tang Clan’s album “Once Upon a Time in Shaolin” for $2 million, thus taking it off the market, as he is aiming to do with West’s latest release — but the originating idea for the Wu-Tang sale came from the musicians, not their acquisitive patron. (Side note: Now that album is also posing a bit of a legal headache for Shkreli.) West, who was on hand to debut his Yeezy Season 3 fashion designs and “The Life of Pablo” later Thursday at New York’s Madison Square Garden, seemingly intends to offer mass access to his music.
Shrkeli’s Twitter feed contained other news-cycle hijack attempts and sly nods to his controversial stature, such as this one:
I am now available for motion picture roles (Hollywood ONLY) filming in 2016-2017. DM me!
— Martin Shkreli (@MartinShkreli) February 11, 2016
Whether Shkreli’s $10 million bid to corner the Kanye West market was as successful as Turing’s was for the old drug Daraprim — for which Shkreli jacked up the price by 5,000 percent — seems unlikely. Meanwhile, we noticed that one of our visual comments about Shkreli (and a certain other art-of-the-deal-er), posted on Feb. 4 after he appeared before Congress to discuss his company’s drug-pricing practices, made its way to his corner of the Twittersphere as well. Our original is posted after the version from Shkreli’s feed below:
The face of a winner @MartinShkreli pic.twitter.com/btYsrvxSb1
— Josh Baranski (@josh_baranski) February 10, 2016
How exactly did this become the face of 2016?: https://t.co/1x6K0ApMo2 @realDonaldTrump @MartinShkreli pic.twitter.com/iTyE6AIbiw
— Truthdig (@Truthdig) February 4, 2016
–Posted by Kasia Anderson
Your support matters…Independent journalism is under threat and overshadowed by heavily funded mainstream media.
You can help level the playing field. Become a member.
Your tax-deductible contribution keeps us digging beneath the headlines to give you thought-provoking, investigative reporting and analysis that unearths what's really happening- without compromise.
Give today to support our courageous, independent journalists.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.